Jiangsu Institute of Parasitic Diseases
🇨🇳China
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)The Chinese-made Praziquantel for Treatment of Schistosoma Haematobium
Phase 3
- Conditions
- Schistosomiasis Haematobia
- Interventions
- Drug: Companion Tablet
- First Posted Date
- 2017-04-28
- Last Posted Date
- 2017-04-28
- Lead Sponsor
- Jiangsu Institute of Parasitic Diseases
- Target Recruit Count
- 120
- Registration Number
- NCT03133832
- Locations
- 🇹🇿
NTD office, Pemba,Ministry of Health, Zanzibar, Pemba, Zanzibar, Tanzania
News
No news found